Finance BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN), Sets a $640 PTSeptember 15, 20250 Regeneron Prescription drugs, Inc. (NASDAQ:REGN) is without doubt one of the finest low cost shares to purchase for novices. In…
